Johnson & Johnson Declines on Efforts to Support Nursing
Johnson & Johnson (NYSE:JNJ) shares moved lower Thursday, on its decision to expand its efforts to champion the nursing workforce and improve access to quality care for communities around the world. These efforts are part of J&J CareCommunity, a new social impact platform that focuses the resources and expertise of J&J and J&J Foundation to support nurses at every step of their career journey and strengthen health systems worldwide. The expansion aims to help address the global shortfall of nurses, which will reach approximately 4.5 million by 2030, driven in part by burnout and low morale, contributing to a significant gap in care and poorer patient outcomes.“For health-care to work, it takes nurses. They are leaders, innovators and changemakers within our health systems. J&J CareCommunity enables us to double down in our efforts to support nurses at this pivotal point. Together with our partners, we aim to equip nurses with the skills and support they need to drive meaningful change for patients around the world,” said Vanessa Broadhurst, Executive Vice President, Global Corporate Affairs at Johnson & Johnson.This morning’s news release points out the Flagship J&J CareCommunity programs advance solutions to elevate, empower and equip nurses in collaboration with leading academic institutions, health organizations and local authorities. The programs include the 2025 class of J&J Nurse Innovation Fellows, a groundbreaking, one-year, team-based fellowship for nurse leaders focused on nurse-led innovation and leadership to drive transformative change.JNJ shares lost 96 cents to $156.34.
Recent Posts

Romanian Inflation Ends Tumultuous Year in Politics Close to 10%

UK Boosts Support For Offshore Wind in Bumper Auction

Ireland Is Trying to Get Back on the Data Center Bandwagon

Notice Concerning Change of Representative Executive Officer

Polish Recycler Bets Millions on Europe’s Critical Metals Push

Blistering Metals Rally Sends Silver, Tin and Copper to Records

Wellington Management Appoints Alex Behm to Strengthen Secondaries Capabilities

TCS and AMD Announce Strategic Collaboration to Drive AI Adoption at Scale

New data reinforces Ipsen’s commitment to bringing solutions and addressing care gaps in neurological diseases at TOXINS

TOXINS 2026: Clinical Updates on Galderma’s Leading Neuromodulator Portfolio Further Reinforce Its Leadership in Injectable Aesthetics


